Goldman, Sachs

Goldman Sachs Maintains Confidence in Nike Despite Market Headwinds

01.02.2026 - 06:09:04 | boerse-global.de

Nike US6541061031

Goldman Sachs Maintains Confidence in Nike Despite Market Headwinds - Foto: über boerse-global.de

As the new trading year gets underway, Nike Inc. finds itself navigating a complex landscape of analyst confidence, shifting institutional investment, and strategic realignments in key global markets.

A significant operational shift is scheduled for February 2026 in India, a crucial growth market. Management of Nike's online platform will transition to the local e-commerce specialist Nykaa. This partnership is designed to leverage Nykaa's domestic logistics expertise to enhance delivery speeds and streamline return processes for customers. Concurrently, Nike will discontinue certain services in the region, including the "Nike By You" customization offering and its SNKRS web platform.

Analyst Stance: A Slight Adjustment

On January 29, analysts at Goldman Sachs reiterated their "Buy" rating on the sportswear giant's shares. However, they made a minor downward revision to their price target, adjusting it to $76 from a previous $77. This assessment comes during a period of notable underperformance for the stock. Over the preceding twelve months, Nike's share price recorded substantial declines, a trend that contrasted with gains posted by the broader S&P 500 index.

Should investors sell immediately? Or is it worth buying Nike?

Institutional Sentiment Shows Divergence

Recent regulatory filings for the third quarter have revealed a cautious stance among some major investors. Audent Global Asset Management divested the majority of its Nike holdings, retaining a position valued at approximately $922,000. Similarly, Truist Financial Corp. reduced its exposure by 5.4%, selling more than 20,000 shares. Despite this sell-off, Truist's remaining stake remains significant, valued at nearly $25 million.

China Continues to Pose Challenges

These strategic moves are set against a backdrop of mixed financial results. For its second fiscal quarter ending November 30, 2025, Nike reported performance that painted a nuanced picture. Persistent revenue declines in the Greater China region remain a particular headwind for the company. Management has indicated a renewed focus on innovation within the sports performance category as a key strategy to regain momentum in this vital market.

All eyes will be on the next quarterly earnings report, expected in March 2026, for indications of whether these strategic recalibrations are beginning to yield results.

Ad

Nike Stock: Buy or Sell?! New Nike Analysis from February 1 delivers the answer:

The latest Nike figures speak for themselves: Urgent action needed for Nike investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 1.

Nike: Buy or sell? Read more here...

So schätzen die Börsenprofis Goldman Aktien ein!

<b>So schätzen die Börsenprofis  Goldman Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
US6541061031 | GOLDMAN | boerse | 68539652 |

Weitere Meldungen

ANALYSE-FLASH: Goldman senkt Ziel für Henkel auf 70 Euro - 'Sell' Die US-Investmentbank Goldman Sachs hat das Kursziel für Henkel DE0006048432 vor Quartalszahlen von 73 auf 70 Euro gesenkt und die Einstufung auf "Sell" belassen. (Boerse, 02.04.2026 - 12:35) weiterlesen...

ANALYSE-FLASH: Goldman hebt Ziel für Evonik auf 20 Euro - 'Buy' Die US-Investmentbank Goldman Sachs hat das Kursziel für Evonik DE000EVNK013 vor Quartalszahlen von 18 auf 20 Euro angehoben und die Einstufung auf "Buy" belassen. (Boerse, 02.04.2026 - 11:20) weiterlesen...

ANALYSE-FLASH: Goldman hebt Rheinmetall auf 'European Conviction List' - 'Buy' Die US-Investmentbank Goldman Sachs hat die Rheinmetall-Aktie DE0007030009 in die "European Conviction List" für besonders aussichtsreiche Werte aufgenommen. (Boerse, 01.04.2026 - 19:05) weiterlesen...

AKTIE IM FOKUS: Goldman Sachs treibt kräftige Rheinmetall-Erholung voran Die Aktie von Rheinmetall DE0007030009 hat sich am Mittwoch im freundlichen Gesamtmarkt weiter von ihrem am Montag erreichten Elf-Monats-Tief nach oben hin abgesetzt. (Boerse, 01.04.2026 - 16:51) weiterlesen...

ANALYSE-FLASH: Goldman senkt Ziel für Lanxess auf 21 Euro - 'Neutral' Die US-Investmentbank Goldman Sachs hat das Kursziel für Lanxess DE0005470405 vor Zahlen zum ersten Quartal von 23 auf 21 Euro gesenkt und die Einstufung auf "Neutral" belassen. (Boerse, 01.04.2026 - 12:34) weiterlesen...

ANALYSE-FLASH: Goldman hebt Sartorius Stedim Biotech auf 'Buy' - Ziel gesenkt Die US-Investmentbank Goldman Sachs hat das Kursziel für Sartorius Stedim FR0013154002 von 235 auf 214 Euro gesenkt, die Aktien aber von "Neutral" auf "Buy" hochgestuft. (Boerse, 30.03.2026 - 09:04) weiterlesen...